VeriMomБезопасен ли 4-butylresorcinol при беременности?
No harmonised CLP reproductive classification or SCCS/CIR reproductive advisory was found for 4‑butylresorcinol (ECHA substance page and registration dossiers). Peer‑reviewed literature on this substance deals with topical depigmentation/tyrosinase inhibition and formulation/irritation, not developmental/reproductive toxicity, so there is no evidence to justify a reproductive hazard score. Topical use can result in low but measurable exposure in adults (see formulation/penetration studies). ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.126.948?utm_source=openai))
Pregnancy-safe products containing 4-butylresorcinol
Related ingredients
Frequently asked questions
- Безопасен ли 4-butylresorcinol при беременности?
- No harmonised CLP reproductive classification or SCCS/CIR reproductive advisory was found for 4‑butylresorcinol (ECHA substance page and registration dossiers). Peer‑reviewed literature on this substance deals with topical depigmentation/tyrosinase inhibition and formulation/irritation, not developmental/reproductive toxicity, so there is no evidence to justify a reproductive hazard score. Topical use can result in low but measurable exposure in adults (see formulation/penetration studies). ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.126.948?utm_source=openai))
- Безопасен ли 4-butylresorcinol при грудном вскармливании?
- As for pregnancy: no evidence or regulatory classification indicating reproductive or lactation-specific hazard was found. Topical use implies low but measurable systemic exposure in adults; therefore breastfeeding exposure is considered low/measurable but no data show transfer in milk or nursing‑infant effects. ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.126.948?utm_source=openai))
- Безопасен ли 4-butylresorcinol для кожи малыша?
- No infant‑specific hazard or mechanistic data were identified. Per the scoring rules, because 4‑butylresorcinol has measurable dermal availability in topical formulations for adults, baby exposure is increased by +1 (immature barrier, higher surface‑area:weight), so exposure is rated moderate. No studies demonstrating infant-specific toxicity were found. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/39326268/?utm_source=openai))
- Как VeriMom оценивает 4-butylresorcinol?
- VeriMom оценивает 4-butylresorcinol в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы 4-butylresorcinol при беременности?
- См. наш список безопасных альтернатив 4-butylresorcinol с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.